5'-Iodoresiniferatoxin |
| Catalog No.GC16801 |
TRPV1 (VR1) receptor antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 535974-91-5
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
| Cas No. | 535974-91-5 | SDF | |
| Chemical Name | ((2R,3aR,3bS,6aR,9aR,9bR,10R,11aR)-2-benzyl-6a-hydroxy-8,10-dimethyl-7-oxo-11a-(prop-1-en-2-yl)-3b,6,6a,7,9a,10,11,11a-octahydro-3aH-2,9b-epoxyazuleno[5',4':3,4]benzo[1,2-d][1,3]dioxol-5-yl)methyl 2-(4-hydroxy-3-iodo-5-methoxyphenyl)acetate | ||
| Canonical SMILES | IC(C=C(C=C1OC)CC(OCC2=C[C@@H]3[C@]([C@H](C)C4)([C@H](C=C(C)C5=O)[C@@]5(C2)O)O[C@@]6(CC7=CC=CC=C7)O[C@H]3[C@@]4(C(C)=C)O6)=O)=C1O | ||
| Formula | C37H39IO9 | M.Wt | 754.6 |
| Solubility | Soluble in DMSO and to 100 mM in ethanol | Storage | Desiccate at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.3252 mL | 6.626 mL | 13.2521 mL |
| 5 mM | 0.265 mL | 1.3252 mL | 2.6504 mL |
| 10 mM | 0.1325 mL | 0.6626 mL | 1.3252 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC60096 Brilacidin tetrahydrochloride
- GC11024 AG-213
- GC15346 RN 1747
- GC10181 L-803,087 trifluoroacetate
- GN10566 Gypenoside XVII
- GC19383 WNK463
- GC13260 Pyrene azide 1
- GC14928 Lexacalcitol
- GN10792 Caffeic acid
- GC34621 IACS-8968
- GC11143 NS 11394
- GC39199 Thymopentin acetate
- GC38081 Theliatinib
- GC17458 Sulfamerazine sodium salt
- GC10626 KU14R
- GC32844 BMS-986195
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *